Financial Performance - The company's operating revenue for Q1 2022 was RMB 1,008,791,650.49, representing a year-on-year increase of 24.62%[4] - The net profit attributable to shareholders of the listed company was a loss of RMB 188,857,673.53, with a net profit excluding non-recurring gains and losses of RMB 247,303,881.96[4] - The net loss for Q1 2022 was CNY -188,857,673.53, an improvement from CNY -263,577,641.24 in Q1 2021, showing a narrowing of losses[19][20] - The company reported a basic and diluted earnings per share of -0.01 yuan[4] - The basic earnings per share for Q1 2022 was CNY -0.01, compared to CNY -0.03 in Q1 2021, reflecting a slight improvement in per-share performance[20] Cash Flow - The net cash flow from operating activities was negative at RMB 78,717,568.73[4] - In Q1 2022, the company reported cash inflows from operating activities of CNY 1,400,351,894.16, a significant increase from CNY 889,293,749.03 in Q1 2021, representing a growth of approximately 57.4%[21] - The net cash flow from operating activities was negative at CNY -78,717,568.73, compared to CNY -62,701,796.33 in the same period last year[21] - The company's total cash inflow from operating, investing, and financing activities resulted in a net decrease in cash and cash equivalents of CNY -349,391,488.87 for the quarter[22] - Cash and cash equivalents decreased to CNY 1,830,251,637.44 from CNY 2,181,033,706.12 year-over-year, indicating liquidity challenges[11] Assets and Liabilities - Total assets at the end of the reporting period were RMB 32,517,748,225.90, down 1.88% from the end of the previous year[5] - The total assets decreased to CNY 32,517,748,225.90 from CNY 33,139,601,124.96 at the end of 2021, reflecting a reduction in current assets[12][17] - The company's total liabilities decreased to CNY 15,160,711,996.68 from CNY 15,741,267,052.61, suggesting improved debt management[14][17] Research and Development - Research and development expenses totaled RMB 88,582,206.51, accounting for 8.78% of operating revenue, a decrease of 2.57 percentage points compared to the previous year[5] - Research and development expenses increased to CNY 22,918,747.98, up from CNY 21,822,064.17 in Q1 2021, indicating a focus on innovation[18] Shareholder Information - The top ten shareholders held a total of 10,000,000,000 shares, with the largest shareholder, Shanghai Lianhe Investment Co., Ltd., holding 8,057,201,900 shares, accounting for 58.01%[8] Government Support and Non-Recurring Items - The company received government subsidies amounting to RMB 6,454,805.86 during the reporting period[6] - The total amount of non-recurring gains and losses was RMB 58,446,208.43[6]
和辉光电(688538) - 2022 Q1 - 季度财报